| Similar Articles |
|---|
 |
Pharmaceutical Executive
August 1, 2012 |
Piramal Pivots for Growth Western drug makers face an unlikely challenge from India's Piramal Healthcare, which has divested its big stake in branded generics for the risky embrace of new drug innovation.   |
BusinessWeek
April 18, 2005
Manjeet Kripalani |
India: Bigger Pharma Tougher patent protection laws are spurring rapid growth in new drug research across India. |
Chemistry World
May 3, 2012
Akshat Rathi |
Ranbaxy launches new anti-malarial Synriam It is the first recently developed antimalarial that is not based on artemisinin, one of the most effective treatments for malaria, which has begun to suffer from problems with resistance in recent years. |
Chemistry World
January 30, 2014
Phillip Broadwith |
AstraZeneca ends R&D in India Pharmaceutical firm AstraZeneca is quitting its R&D site in Bangalore, India. |
BusinessWeek
January 12, 2004
Manjeet Kripalani |
India: Big Pharma's New Promised Land? Drugmakers are heeding the siren call of its well-trained, cheap chemists. |
Chemistry World
August 14, 2015
Jennifer Newton |
No one should be denied medication 'My whole fight today, for the third world, is for access to medicine at affordable prices,' attests Indian generics manufacturer Cipla chairman Yusuf Hamied. |
Chemistry World
March 6, 2015
Sanjay Kumar |
Scientists left unimpressed by Indian budget The Indian government's 'big-bang' budget has left the country's science community sorely disappointed. |
InternetNews
December 6, 2005
Colin C. Haley |
Microsoft Plans 30 New R&D Centers Microsoft Chairman Bill Gates kicked off a four-day India trip by outlining a plan to build 30 new innovation centers around the world, including one in the tech-heavy Indian city of Bangalore. |
InternetNews
December 5, 2005
Colin C. Haley |
Intel India Earmarks $1B For India Intel will invest more than $1 billion in India over the next five years to increase its presence in a country that continues to evolve into an economic powerhouse. The chipmaker's five-year plan includes R&D and VC investment. |
Chemistry World
August 23, 2012
Simon Campbell |
Protecting patients at all costs A new funding model is urgently required to deliver innovative medicines that meet the medical needs of the 21st century and contribute to economic growth. |
Chemistry World
February 12, 2015
S Umapathy |
Indian science at the crossroads How should Indian scientific research evolve? |
Chemistry World
February 13, 2012 |
Building a nation of scientists Goverdhan Mehta talks to Sheena Elliott and Elinor Richards about the progress of science in India and the challenges scientists face |
InternetNews
September 9, 2009 |
EMC Opens Wallet to Expand R&D Efforts in India EMC plans to spend $1.5 billion over the next five years in Asia's third-largest economy. |
InternetNews
December 7, 2005
Colin C. Haley |
Microsoft Plans Another $1.7B For India The company will put more money into India in hopes of getting more software out of it. |
Bio-IT World
July 11, 2002
Kevin Davies |
Counting the Cost of Drug Discovery Much of the trouble ensnaring the drug industry is blamed on the exorbitant cost of drug discovery. Tangible proof that the bio-IT revolution will economize drug discovery is emerging, but there is still a long way to go. |
Chemistry World
January 10, 2012
Rajesh Parishwad |
Indian science needs to raise its game Despite a three-fold increase in public R&D in the last five years, Indian science and research is yet to make a significant impact on the global scene according to Indian Prime Minister Manmohan Singh. |
Chemistry World
December 2006
Derek Lowe |
Opinion: In the Pipeline A look at the story behind the growing investment by western companies in medicinal chemistry research in China. |
Pharmaceutical Executive
September 1, 2008
Sarah Houlton |
Doing More With Less In order to take a big step forward, GlaxoSmithKline looks to employ smaller licensing deals and business units. |
Pharmaceutical Executive
April 1, 2012 |
Leading from the South India's most prominent scientist sets a new agenda for pharma in emerging markets. |
Pharmaceutical Executive
October 1, 2011
Amrita Ghaswalla |
Changing the Dialogue No industry leader is more closely associated with the goal of seeding the globe with low-cost generics than Mumbai-based Cipla Chairman Y.K. Hamied. |
Chemistry World
December 18, 2015
Ned Stafford |
India maintains scientific edge despite static funding Researchers in India are increasingly authoring articles published in 'high-quality scientific publications' despite continued stagnation in Indian government spending for research, according to a new Nature Index analytics report. |
Chemistry World
October 17, 2014
Dinsa Sachan |
Indian manufacturers hit back over quality claims The Indian pharmaceutical industry has asked its government to sue authors of a study published by the US National Bureau of Economic Research in early September. |
Chemistry World
October 8, 2010
Akshat Rathi |
India calls for ambitious increase in science funding The Scientific Advisory Council to the Prime Minister of India has advised the government to increase its science funding from less than 1 per cent of GDP to up to 2.5 per cent by 2020. |
Global Services
July 7, 2007
Shyamanuja Das |
The Acquisitive Indian Indian tech and outsourcing companies seem to be on a buying spree. In the last few months, every Indian company worth its name has either acquired another or has set aside a few million to do so in the near future. |
Chemistry World
July 25, 2012 |
Pharma Industry May Suffer as India Looks to Generics India plans to provide free generic drugs to half its population. |
Chemistry World
July 15, 2008
Hepeng Jia |
Testing Times for New Liver Drug AstraZeneca is set to start clinical trials of a liver cancer drug developed for Chinese patients. |
BusinessWeek
September 3, 2007
Manjeet Kripalani |
A Red-Hot Big Blue In India From inking deals to hiring the best workers, IBM is leading its tech services rivals in India. |
Chemistry World
August 29, 2007
Killugudi Jayaraman |
India Announces Plans for Its First Nanopark Already the home for India's leading software and biotech firms, Bangalore is now aiming to attract businesses in another emerging area: nanotechnology. |
BusinessWeek
February 27, 2006
Einhorn & Kripalani |
In India, Selling Generics Used To Be So Easy Suddenly, Indian drugmakers Dr. Reddy's and Ranbaxy have a host of copycat rivals. |
Chemistry World
August 3, 2012
Andrew Turley |
Pfizer secures Sandwich buyer Pfizer has found a buyer for its R&D site in Sandwich, UK: the site -- now called Discovery Park -- has been bought by a private consortium, according to Kent County Council. |
IndustryWeek
February 1, 2004
Traci Purdum |
GM Taps India For IT And R&D The leading automaker invests $21 million to set up shop in Bangalore. |
BusinessWeek
October 10, 2005
Manjeet Kripalani |
India: A Quiet Shopping Spree So far, foreign companies being bought by Indian players are small - but that's likely to change |
Pharmaceutical Executive
July 3, 2007 |
Thought Leader: Connected Markets, Rob Dhoble It used to be that pharma companies had one marketing strategy for the US and other developed nations, a second strategy for emerging countries, and a third, mostly focused around access, for the developing world. But in a global environment, that doesn't work. |
The Motley Fool
August 30, 2006
Brian Gorman |
An Integrated India Strategy From EADS Plans to outspend Boeing in India could mean more commercial and defense business in the country. Investors, take note. |
The Motley Fool
January 22, 2010
Tim Hanson |
The Biggest Investment Opportunity This Year Why power is the way to play India. |
Global Services
June 10, 2008
Shyamanuja Das |
Outsourcing to India: 1998 Vs. 2008 If you want to offshore to India for the same reasons some of your peers did in 1998, then do so at your own risk. |
Chemistry World
April 15, 2008
Killugudi Jayaraman |
Indian Spin-Outs Set to Flourish A bill that could help more Indian academics commercialize their research is set to be passed by the country's parliament in June. |
BusinessWeek
December 8, 2003
Michael J. Mandel |
Commentary: Meeting the Asian Challenge As India and China ascend the economic ladder, here are steps that America can take to boost the four key components of innovation: R&D spending, education, finance for invention, and the national willingness to take risks. |
IndustryWeek
December 1, 2008
Adrienne Selko |
The Rise Of Indian Manufacturing As India's production capabilities increase, U.S. manufacturers would do well to craft a global strategy that addresses the emergence of this no-longer-slumbering giant. |
CFO
September 1, 2008
Kate O'Sullivan |
The Taxman Cometh India sees "big dollar signs" in the legions of foreign customers of its IT services industry. |
Bio-IT World
November 2006
Kevin Davies |
Building a Bridge Over Pharma with IT More than 100 enthusiastic delegates bridging the full breadth of the drug development pipeline gathered recently for the second annual Bridging Pharma and IT conference. Here are some highlights. |
Chemistry World
February 20, 2013
Laura Howes |
UK-India projects launched To coincide with the prime minister's visit to India, UK universities have announced a series of research partnerships and scholarships intended to boost the trade and education links between the UK and India. |
IEEE Spectrum
September 2007
Seema Singh |
Indian Start-ups Lure Silicon Valley Cash Tech giants invest in Bollywood, e-government, and more. |
Information Today
October 24, 2013 |
NISO's Open Discovery Initiative Releases Recommended Practice Draft This recommended practice from the National Information Standards Organization provides guidelines for content providers and discovery service creators on how to address issues that arise in the use of indexed search as part of library discovery services. |
Information Today
February 26, 2015 |
NISO Releases White Paper on the Future of Library Resource Discovery NISO (National Information Standards Organization) published a white paper, "The Future of Library Resource Discovery," which summarizes the current discovery environment. |
The Motley Fool
February 28, 2007
Brian Lawler |
Discovery Prepares for Its Fate Discovery Labs announces its quarterly financial results as it prepares for another meeting with the FDA. Investors, take note. |
The Motley Fool
June 9, 2006
John Finneran |
IBM: "I" Stands for India IBM will invest $6 billion in India -- but why? |
The Motley Fool
April 12, 2011
Brian Orelli |
Merck Joins the Low-Margin Party The American drugmaker announces that it is partnering with Sun Pharma to establish a joint venture to sell branded generics in emerging markets. |
Chemistry World
February 3, 2015
Sanjay Kumar |
India's chemistry challenges While India is yet to catch up with the global cutting edge technologies, some of its interventions have made global headlines. |
IEEE Spectrum
June 2007
Seema Singh |
Delhi's Defense Spending Spree As India upgrades its arsenal, U.S. military contractors hope to cash in. |
